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Context. One palliative care approach that is increasingly being used at home
for relieving intolerable suffering in terminally ill patients is continuous sedation
until death. Its provision requires a multidisciplinary team approach, with
adequate collaboration and communication. However, it is unknown how general
practitioners (GPs) and home care nurses experience being involved in the use of
sedation at home.
Objectives. To present case-based GP and nurse descriptions of their
collaboration, roles, and responsibilities during the process of continuous
sedation until death at home in Belgium, The Netherlands, and the U.K.
Methods. We held in-depth qualitative interviews with 25 GPs and 26 nurses
closely involved in the care of 29 adult cancer patients who received continuous
sedation until death at home.
Results. We found that, in Belgium and The Netherlands, it was the GP who
typically made the final decision to use sedation, whereas in the U.K., it was
predominantly the nurse who both encouraged the GP to prescribe anticipatory
medication and decided when to use the prescription. Nurses in the three
countries reported that they commonly perform and monitor sedation in the
absence of the GP, which they reported to experience as ‘‘emotionally
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decision making and provision of continuous sedation until death at home. These
differences, among others, may be the result of different organizational contexts
in the three countries such as the use of anticipatory medication in the
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Continuous sedation until death (from here
onward referred to as sedation) is often used
as a last resort option for relieving intolerable
refractory (i.e., untreatable) symptoms of
terminally ill patients in which the patient’s
consciousness is lowered until the time of
death.1e4 Previous international research has
shown that sedation is commonly used in
different countries and that systematic
differences occur in its practice among
countries.5e8 Guidelines on sedation were
developed in The Netherlands in 2005 and
in Belgium in 2010.2,3 In 2009, the European
Association for Palliative Care (EAPC) pub-
lished a framework of recommendations for
the use of sedation.4 No sedation guidelines
exist in the U.K.
Although these guidelines have been pri-
marily developed for supporting physicians
in their practice of sedation, recommenda-
tions also may have consequences for tasks
performed by nurses involved in the care for
the patient.9 Thus, guidelines recommend
that GPs should bear final responsibility for
the performance of sedation, but studies
have shown that nurses are also important
participants in the decision-making process
and the implementation of sedation.2e4 As
palliative care requires a team approach ac-
cording to the World Health Organization,10
it is surprising that studies have been either
focused on physicians’ or nurses’ practices
and attitudes regarding the complex realities
of the performance of sedation, and have
not studied these issues in-depth from a dou-
ble perspective.
For instance, a British study suggested that
U.K. nurses have a key role in activatinganticipatory prescriptions, although research
into this issue is scarce.11 In the U.K., these
anticipatory prescriptions are written by the
GPs for patients who wish to remain at
home in the last few days or weeks to ensure
that there is no delay in responding to a
symptom if it occurs.12 The anticipatory
medication that is prescribed in advance
consists of sedatives alongside other
commonly used drugs at the end of life.
These are often referred to as the ‘‘just in
case’’ medications and are kept in the pa-
tient’s home.13
Furthermore, recent Belgian and Dutch
studies found that home care nurses were
less often involved by GPs in the decision-
making process of sedation than nurses work-
ing in institutions.9,14e16 However, they were
frequently involved in the performance and
monitoring of sedation at home in the
absence of the GP in a substantial number
of cases.9,14,15 Another substantial number of
Dutch nurses made independent decisions
concerning the dosage of medication.14 The
authors of these studies, therefore, have
raised questions regarding the autonomy
and responsibilities of nurses at home, and
their collaboration with the GPs during
sedation.9,14,15
Especially in the home care setting, the prac-
tice of sedation can be challenging for the GPs
and the nurses.17e20 Barriers surrounding the
adequate performance of this practice at
home as experienced by the GPs and nurses
include a lack of knowledge of GPs about
this practice; obstacles regarding the availabil-
ity of medications, medical equipment, and
clinical staff at all times; and a lack of time,
coordination of the patient’s care at home,
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professionals.9,21e24 Another qualitative study
in the U.K. reported additional challenges
such as resourcing concerns, professional
expertise/experience, professionals’ relation-
ships with patients, and professionals’ relation-
ships with other professionals.25
To explore qualitatively and to seek to
explain differences in reported practices of
sedation among different countries, the U.K.
Netherlands Belgium International Sedation
Study (UNBIASED study) has been set up in
Belgium, The Netherlands, and the U.K.25
The present study is part of the UNBIASED
study and focuses on the reports of physicians
and nurses in the home setting regarding the
decision-making processes, performance, and
monitoring of sedation.
The goal of our qualitative in-depth inter-
view study was to investigate descriptions by
the GPs and nurses of their collaboration,
roles, and responsibilities during the process
of sedation at home in Belgium, The
Netherlands, and the U.K.Methods
In the larger UNBIASED study, in-depth
interviews were held with physicians, nurses,
and decedents’ relatives in Belgium, The
Netherlands, and the U.K. in 2011e2012 in
hospitals (oncology wards), palliative care units
(in Belgium) or hospices (in the U.K. and The
Netherlands), and at home. We refer to the
published UNBIASED study protocol for a full
description of the methods used.25 The proto-
col and the aide-memoires (or ‘‘interview
guides’’) used in qualitative data collection
were developed in close collaboration among
the countries to ensure comparability of
research conduct, especially with regard to in-
clusion criteria of patient cases.
Ethical Approval
The study was approved in the U.K. by the
Leicestershire, Northampton, and the Rut-
land Research Ethics Committee 1, reference
number 10/H0406/57; in Belgium by the
Ghent University Hospital Ethics Committee,
reference number B670201010174; and in
The Netherlands by the Erasmus MC Medical
Ethical Research Committee, referencenumber NL33327.078.10, V03. Each partici-
pant gave written informed consent before
participating.
Study Design, Setting, and Participants
A qualitative in-depth retrospective case
study design was used to enable exploration
of the practice of sedation from a variety of
perspectives and in terms that relate to ‘‘real-
world’’ practice. By using a case study design,
it is possible to explore practically and ethi-
cally complex situations, as is the practice of
sedation until death. Detailed insights from
well-constructed case studies also have an
explanatory potential.25 Herein, we report per-
spectives from the GPs and nurses in the
home care setting in the three countries.
The GPs and nurses were invited to take part
in a face-to-face interview if they had recently
taken a key role in the care of a patient older
than 18 years, who had died of cancer, and
who had been continuously sedated until
death. Patients who had only received opioids
were excluded. The GP practitioners were
asked to identify patients who before death
had received continuous sedation. If the case
was judged by the GP as suitable for our study,
the GP practitioners sent out the invitations
for interviews to the decedents as well as the
staff most associated with the case. The GPs
and nurses in the three countries were inter-
viewed about no more than three patients.
Procedures
The interviews were held by trained inter-
viewers in private meeting rooms and lasted
approximately 30 minutes. All participants
signed a consent form and consented to the
interview being audiotaped. At the beginning
of each interview, sociodemographic informa-
tion was obtained through a short question-
naire about the interviewee and the patient
(via the GP in the three countries or the nurse
in the U.K.). The interviewer explained that
he/she did not know the details of the
patient’s case, for reasons of anonymity. Partic-
ipants could use the patient records if neces-
sary to support them in their recollection but
were asked to provide relevant information
about the case in an anonymous manner.
The interviews were semistructured and sup-
ported with the use of aide-memoires. Before
the interview study, the aide-memoires had
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views. The aide-memoires focused on partici-
pants’ recollections of the decedent’s care
and the use of sedation in particular. Inter-
viewees were asked to describe the reasons
for the use of sedation, how the decision-
making process evolved, and how sedation
was performed. Finally, the participants were
asked about their general ideas and attitudes
regarding the use of sedation.
Data Analysis
All recordings of the interviews were tran-
scribed verbatim and safeguards were taken to
reduce the risk of breach of confidentiality. Iden-
tifiers were stripped from the transcripts. The
Belgian and Dutch interviews were translated
into English by a professional translation bureau
and checked for accuracy. All interviews were
read in-depth by L. A. and J. A. R., and the main
themes concerning GPs’ and nurses’ collabora-
tion, roles, and responsibilities during the pro-
cess of sedation at home were identified based
on Straus and Corbin’s constant comparative
method.26 This involved labeling small extracts
ofdatawith adescriptive code and thengrouping
similar codes together into a theme. The tran-
scripts were coded exhaustively. Based on these
themes regarding theGPs’ andnurses’ collabora-
tion, roles, and responsibilities during the pro-
cess of sedation at home, a coding tree was
developed by L. A. and J. A. R. and agreed by all
the authors. The interviews were reread and
quotes were selected and classified under the
matching main and subthemes. The selection
and classification was done by L. A. and checked
by J. A. R. The development of the analysis was
discussed with all co-authors in telephone meet-
ings. Finally, quotes per main theme were
selected by L. A. and J. A. R. for publication and
approved by all researchers. For the questions
addressed in this article, wewere able to continue
identification of eligible deaths and recruitment
of physicians and nurses until data saturation
occurred (i.e., no new issues emerging).27Where
possible, we compared theGPs’ andnurses’ com-
ments on the same sedation case.Results
We explored 29 cases of patients with cancer
(11 BE, 10 NL, and 8 U.K.) who had beencontinuously sedated until death at home
with 25 GPs (9 BE, 10 NL, and 6 U.K.) and
26 nurses (11 BE, 8 NL, and 7 U.K.). In 28
cases, both a GP and a nurse had been
involved in the patient’s care at home (11
BE, 9 NL, and 8 U.K.). In one Dutch case,
no nurse had been involved according to the
GP because the patient’s family took care of
the patient until the patient’s death. In 24 (9
BE, 9 NL, and 6 U.K.) of these 28 cases, we
were able to interview both the GP and the
nurse most involved. Characteristics of the
deceased patients, GPs, and nurses may be
found in Table 1.
A home care team had been involved in 24
cases (10 BE, 6 NL, and 8 U.K.) and a specialist
palliative home care team in 20 cases (7 BE, 9
NL, and 4 U.K.). In two Belgian cases, the GPs
reported that a specialist palliative home care
team had not been involved but that they
themselves were specialized in palliative care.
In the interviews, the GPs and nurses in the
three countries reported on their collabora-
tion, roles, and responsibilities during the
decision-making process, performance, and
monitoring of sedation at home.
Decision-Making Process of the Use of Sedation
Until Death
We found differences across countries in the
decision-making process, who discusses seda-
tion with the family, who is involved in the final
decision and how, and who makes the final
decision.
In the three countries, the GPs and nurses
said that nurses often coordinated the care at
home. They also described how nurses sup-
ported the patient and the patient’s family
when there were emotional issues toward the
end of the patient’s life.
GP, BE, Case 7: Those nurses played a very,
shall I say yes covering role, a coaching
role. They take over a lot [of the tasks].
Nurse no. 2, U.K., Case 1: I remember my role
being more related to the emotional side of
things. I didn’t havemuch contact with the pa-
tient or the district nurses towards the end of
his/her life because they were coordinating
things by then and the patient had a syringe
driver in situ so they were going in every day
and, as a specialist nurse, unless there are spe-
cific emotional or symptom issues, I would
Table 1
Characteristics of Patients, Physicians, and Nurses
Characteristics Patients, n¼ 29 Physiciansa, n¼ 25 Nursesa, n¼ 26
Cases With Both
Perspectives, n¼ 24
Country
Belgium 11 9 11 9
The Netherlands 10 10 8 9
U.K. 8 6 7 6
Age
#40 2 2 6 n/a
41e50 1 6 8
51e60 3 9 7
61e70 8 2 0
71e80 10 0 0
>80 5 0 0
Not stated 0 6 5
Gender
Male 12 14 2 n/a
Female 17 11 23
Not stated 0 0 1
Diagnosis
Abdominal/stomach 1 n/a n/a n/a
Bladder/renal 1
Colorectal 2
Brain/glioblastoma 1
Breast 4
Gynecological 1
Facial maxillary/esophageal 1
Gallbladder/pancreatic 3
Leukemia/myelofibrosis/myeloma 2
Lung/mesothelioma 8
Melanoma 1
Peritoneal 2
Prostate 2
aMore than one could have been interviewed.
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they can contact me for advice but I wouldn’t
necessarily be visiting regularly because the
district nurses were going in daily and things
were controlled.
The nurses in the studied countries also
often explained that they had an explanatory
role, informing the patient and the family
about what one can expect toward the end
of life. Nurses reported that they informed
patients and their families about the possibil-
ities at the end of life, such as sedation and
euthanasia in Belgium and The Netherlands,
and the use of anticipatory medication in
the U.K.
Nurse no. 2, UK, Case 1: I do a lot of
explanation with the family as to what they
[anticipatory medication] are and when
they’re used.
Although some nurses in Belgium and The
Netherlands reported that they discussed the
option of sedation with patients and families,several respondents in these countries stated
that the option of sedation was mostly dis-
cussed by the GP. The GP also discussed it
sometimes with the home care nurses or the
palliative team. In Belgium and The
Netherlands, it was usually the GP who made
the final decision to use sedation and reported
themselves as having overall responsibility,
even where the nurses suggested when seda-
tion should be begun or increased the sedative
medication within prescribed parameters.
GP, NL, Case 1: The decision [to sedate] lies
with me because you cannot just perform
palliative sedation in any situation.
Interviewer: And who else was involved in the
decision making?
GP, NL, Case 1: If you take a decision about
dying, I want to have the conversation in
the first instance only with the patient.
Then I have a second conversation with
the most involved relative. What I also always
say is that the decision [to sedate] is never
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care team, and I also let them decide.
Nurse, NL, Case 1: It [sedation] is not our
decision, it is really a decision between the
GP and the patient, who [the GP] then
decides to start with it.
Interviewer: And you yourself were present at
that conversation?
Nurse, NL, Case 1: At the moment when the
GP discussed sedation with the patient
today, I was present. Not before.
Interviewer: And who else was present during
that conversation?
Nurse, NL, Case 1: The patient’s wife.
Nurse, BE, Case 7: I think that the indication
of that decision often lies with the nurse.
But the GP always decides. The GP is the
one who says ‘‘the syringe driver will or will
not be placed,’’ but I think we indicate the
moment. Especially the nurses, because we
are the ones who are most often with the pa-
tient day by day.
Nurse, BE, Case 9: The doctor is still the one
responsible, that’s good because in the end
it is the nurse who puts in the pump and in-
creases the medication.
The role of the nurses in the decision-making
process was, according tomost of them, to advo-
cate the patient’s perspective and needs and
affirm the GP’s decision to sedate.
Nurse, NL, Case 1: The doctor really takes
the decision, we only suggested that the
patient also had told us that he/she can’t
take it anymore and we just supported
him/her. We see it as well, not that I’m
saying to the doctor ‘‘you should do that
now’’ because we are not doctors, it doesn’t
work like that.
Nurses and GPs from the U.K. described a
rather different decision-making process about
the use of sedation compared with those from
Belgium and The Netherlands, as well as dif-
ferences in the GP and nurse roles. The GPs
and nurses from the U.K. described that first
it was necessary to decide to prescribe the
anticipatory medication and second, it was
necessary for a decision to be made to imple-
ment the prescription and use the medication.Several British GPs and nurses reported that it
is often the nurse who both encourages the GP
to prescribe the anticipatory medication and
then takes the responsibility for deciding
when to use prescribed medication for the
patient.
Interviewer: And what about the district
nurses - do they come sometimes and say
to you, ‘‘I think .’’
GP, U.K., Case 5: Yeah, they’re generally
quite good and they generally will suggest
if they think that somebody’s at the stage
of needing a syringe driver, and they prob-
ably deal with it a lot more than we [GPs]
do really.
Nurse no. 2, U.K., Case 5: I think the district
nurses have really got to terms with the use
of anticipatory drugs and, whereas I used
to have conversations with GPs where I
would recommend that they prescribe antic-
ipatory drugs and they would then say to me,
‘‘What do you recommend I prescribe?’’
Sometimes, British nurses and GPs reported
that GPs were very wary and afraid of prescrib-
ing or administering medication because of
possible implications for themselves.
GP, U.K., Case 5: I don’t think sedation is
over-used. Perhaps in occasions, as doctors,
we maybe should have thought about putt-
ing drivers in sooner than later.
Interviewer: And why do you think that we
tend to wait and hang on a little bit?
GP, U.K., Case 5: Sometimes I think it’s just
worrying about being too aggressive and
making somebody too sedated and how the
family might react to that. You always worry
about, you give that dose of morphine and
then they stop breathing that second and
then it just looks like you’ve done it. If there
was no family you might do things a bit
differently if you felt that you wouldn’t
have eyes scrutinizing you.
Nurse no. 2, U.K., Cases 1 and 5: I think it’s
very difficult to sort of marry up the GP’s
responsibility for prescribing that sedation
with the patient’s wishes, as in the case of
the patient who wanted to be sedated. It is
difficult to go back to the patient and say,
‘‘I know you don’t want to be awake . but
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never say, ‘‘the doctor won’t prescribe it .
because he/she’s worried about the implica-
tions on him/her.’’
British nurses described how they sometimes
suggested what medication should be used for
sedation, although several of them reported
this should be a team decision.
Nurse no. 2, U.K., Cases 1 and 5: It’s often the
district nursemaking that decision and going
to see the GP and saying, ‘‘time for a syringe
driver.’’ And it depends on the GP and their
knowledge and experience, but quite often
we’re suggesting what they put in it as well.
Nurse, U.K., Case 3: I’ve noted that some-
times nurses will go their own way, which I
think is a huge thing. I strongly believe it
should be a double-up nursing situation. If
you’re making that decision and you feel
that it’s appropriate to start a syringe driver,
I would still always ring the out-of-hours GP,
even though it’s written up, and discuss it. I
think it’s got to be a team decision.
In the U.K., the decision to administer antic-
ipatory medication was sometimes described as
a joint decision between the nurse and the GP,
with the final responsibility lying with the GP.
GP, U.K., Case 6: So it [administering medi-
cation] is always a collaborative decision-
making in some respect. The final sort of
responsibility probably lies with me, but in
fact the actual decision’s been made with
nursing input, and in fact the patients and
staff and the relatives’ wishes as well.
Interviewer: Who made that decision?
Nurse, U.K., Case 6: We make it together with
the GPs. There’s a basic set of drugs written
up that cover the base symptoms. It’s just
deciding when to or if you need to start them.
Interviewer: And was that a nursing decision
to start them?
Nurse, U.K., Case 6: Well, it’s a joint decision
between the nurses and the GP.
Performance of Sedation Until Death
After the decision was made to use (anticipa-
tory) medication, respondents in the three
countries described how it was mainly thenurse who started the syringe driver and
administered the medication, mostly in the
absence of the GP.
Interviewer: Was the GP also present at the
time of the connection of the pump?
Nurse, NL, Case 5:Well here in [place] that is
almost never the case. I worked in [another
place] before and there it was a must; we
would say to the GP ‘‘if you are not there
then we won’t start the sedation.’’ But that
is not common here.
According to some Belgian and Dutch
nurses, the GPs lack knowledge about placing
a syringe driver. Also, starting sedation is a
technical act and several nurses said that they
are more skilled at it than GPs.
Interviewer: Is it also usually the doctor who
starts the sedation, or is that left to the nurse?
Nurse, BE, Case 1: Yes, the nurse usually does
that with someone from the palliative home
care team.
Interviewer: And administering the medica-
tion in the pump e is that also done by
the nurse?
Nurse, BE, Case 1: Yes. We know what should
go in there and we do that. The doctors
don’t start up the syringe driver. They actu-
ally don’t really know that driver. And if
there is a problem at night then we are
also the ones who go because doctors usually
don’t know that.
In a Dutch case, the GP said that he/she did
not find his/her presence necessary at the start
of sedation because the nurse had plenty of
experience. The nurse from that same case
said that he/she found the presence of the
GP desirable, although the GP was mostly not
present.
Interviewer: Have you been present at the
start of sedation?
GP, NL, Case 6: No, I’ve discussed it with the
nurse who was going to administer it, and
whether s/he wanted me to be there. But
well, I think it’s not necessary, because they
have plenty of experience and everything
was said and done and discussed. So yeah,
I don’t need to be present at the start of
sedation I think.
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the start of the sedation, you connected
the pump.
Nurse, NL, Case 6: Yes.
Interviewer: How does that exactly work? Is
there for example a doctor always present
as well?
Nurse, NL, Case 6: No a doctor isn’t always
present, it is desirable that the GP is there,
but that’s usually not the case. No, there is
usually no doctor present.
Another Dutch nurse explicitly said that he/
she had appreciated the GP’s presence while
he/she had started the sedation.
Nurse, NL, Case 4: Well I’m the one who con-
nected the pumps, inserted the needles.
What I found very positive by the way, was
that the GP was present when connecting
the pump. This is very desirable but it’s actu-
ally almost never done.
Interviewer: Oh I think that is special to hear,
that it wasn’t, let’s say, that standard that the
GP stayed?
Nurse, NL, Case 4: Yes, I have said it to the GP
as well, that his/her presence is very nice.
For the family too, because they have been
so long with the GP. It’s just closing a piece
of care, I think it’s very neat.
In a few cases studied in Belgium and The
Netherlands, the GP had started the sedation.
Interviewer: Were you actually present your-
self at the start of the sedation?
GP, NL, Case 8: Yes I have been present, but I
can imagine there might be situations where
it’ll be different, I don’t know.
Interviewer: Okay, but in any case, you were
present for this patient.
GP, NL, Case 8: Yes.
Nurse, NL, Case 8: The GP just gave the
injection.
Interviewer: And does it always go like that, or
do you as a nurse do that too?
Nurse, NL, Case 8: We do it as well, but that
first injection is usually done by the doctor,
yes always actually.Monitoring of Sedation Until Death
In general, the monitoring of sedation until
the patient’s death was not often discussed by
physicians and nurses during the interview in
any of the countries. According to some GPs
and nurses in all countries, this was mostly
the nurse’s task.
Interviewer: So obviously you’re saying that
the Macmillan nurses were involved. I pre-
sume the district nurses were involved as
well?
GP, UK, Case 4: Yeah, district nurses obvi-
ously. The syringe driver was being looked
after by the district nurses.
Several Belgian, Dutch, and British nurses in
our study talked about the responsibility that
they, and colleagues with less experience with
syringe drivers, experienced during sedation.
A British nurse said that although they are
trusted by GPs to make decisions regarding giv-
ing anticipatory medication, nurses also may
struggle with the dilemma of actually adminis-
tering the medication; some reported an
emotional burden relating to uncertainty
about whether the medication had hastened
the patient’s death.
Nurse no. 2, U.K., Cases 1 and 5: Actually,
once the doctors have written the medica-
tion up, it’s up to the nurses to decide
when it’s given and to monitor it and con-
tact the doctor if it’s not working or if the
patients are needing it frequently. And I
remember a very sort of difficult situation
with someone with terminal agitation who
was very near to death, and that dilemma:
‘‘Will this sedation actually kill them?’’ But
they need it because they’re not settled
and they’re a danger to themselves, but it’s
still that sort of emotional burden on the
nurse, sort of like, ‘‘Do I give it?’’ And I sup-
pose in doubt you ask the doctor but we’re
trusted enough to make the decision.
Nurses perceived responsibility especially
when the GP lacked sufficient knowledge and
left the start up and monitoring of sedation
to the nurse.
Nurse no.1, U.K., Case 1: GPs rely on us virtu-
ally for all the information because they just
don’t know the patients or the families. I
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often do not even know how to write a pre-
scription and we have to tell them. They
tend to write up the largest doses straight
away and we will say ‘‘no, I think we should
start with a small dose.’’ They should go
out and visit the patient before prescribing.
Not all of them do that, and this is a big re-
sponsibility on us, especially nurses with less
experience of syringe drivers. It all comes
from experience.
Discussion
Our study provides insight into GPs’ and
nurses’ views and descriptions of their collabo-
ration, roles, and responsibilities during the
decision-making process, performance, and
monitoring of end-of-life sedation at home.
We found that it was the GP who primarily
made the final decision to use sedation in
Belgium and The Netherlands, whereas in
the U.K., many nurses reported that they
encouraged the GP to prescribe the anticipa-
tory medication and then decided themselves
when to use the prescription for the patient.
Nurses in Belgium and The Netherlands
seemed to take on a relatively subordinate
role compared with the U.K., where the use
of sedation was more a team decision. Most
nurses in all three countries reported that
they had themselves performed and moni-
tored sedation until death, often in the
absence of the GP. Several nurses reported
that they felt burdened by the responsibility
of performing and monitoring sedation in
cases where the GP was not present or lacked
knowledge about sedation.
Strengths and Weaknesses
By conducting interviews with GPs and
nurses in three European countries, we were
able to obtain detailed, diverse, and in-depth
knowledge on the collaboration between
health care professionals during the practice
of sedation at home. A major strength of our
qualitative study is the cross-national compari-
son among Belgium, The Netherlands, and
the U.K., which enabled us to identify and
explain possible differences in the practice of
sedation in these countries. Another strength
is that we combined the perspectives of both
GPs and nurses involved in care for the samepatient during sedation at home. This allowed
us to compare how they had experienced their
collaboration during this medical practice. A
strength of our data analysis process is that
two data analysts were involved encoding the
transcripts, with input from the whole research
team. Although our results cannot be general-
ized to the whole population of GPs and
nurses because of the relatively small numbers
of cases and interviews, we believe that our
findings may provide new insights that may
be extrapolated to similar clinical situations.
Comparison With Existing Literature
Belgian and Dutch interviewees in our study
reported that it was mostly the GP who made
the final decision for the use of sedation. This
is in agreement with sedation guidelines that
state that the GP most involved in the patient’s
care bears responsibility for determining the
indications and the decision making for
sedation.2e4 Nurses reported, however, that
they were not always involved in this process
by the GP. This finding is consistent with several
quantitative studies that found that home care
nurses are less often involved in decision mak-
ing than their colleagues in institutions.9,16,28
Unlike institutions where physicians and nurses
work within the same teams and attend daily
multidisciplinary team meetings to review pa-
tient cases, the GPs and nurses at home usually
work separately and do not often see one
another at the patient’s bedside.16,29,30 In
contrast, we found that in the U.K., nurses
reported how they encouraged the GPs to
prescribe anticipatory medication and often
made the decision about when to use the pre-
scription. This proactive and leading role of
nurses in decision making about the adminis-
tration of anticipatory medication for symptom
control has been described in other qualitative
British studies.31,32 Nurses in the three coun-
tries reported that they initiated andmonitored
sedation until the patient’s death, often in
absence of the GP. These practices seem not
to be uncommon as they are also reported in
other quantitative studies among nurses on
sedation at home.9,14 Several respondents in
our study suggested that GPs often lack knowl-
edge about the technical performance of seda-
tion and sometimes about the dosages of
medication that should be used. This is consis-
tent with qualitative and quantitative studies
Vol. 49 No. 1 January 2015 107GP and Nurse Collaboration in Continuous Sedation Until Death at Homereporting that GPs perceived their own lack of
knowledge and technical competence about
symptom control as barriers to providing
good palliative care and were less aware of the
drugs used in syringe drivers.21,31 As GPs are
confronted with patients with unbearable
symptoms needing sedation less often than
are specialists in a hospital, they may not have
adequate knowledge about its use and its per-
formance.5,33 Also, nurses may have greater
experience with drugs and syringe drivers,
and GPs in our study, therefore, may have left
the administration of sedation to them.34
Several quantitative and qualitative studies,
however, have raised questions with respect
to nurses’ responsibilities and emotional
distress when administering sedation on their
own.9,14,31,35 In these studies, ‘‘emotional
distress’’ was understood to mean, among
other things, having ambivalent feelings,
ethical dilemmas, concerns, and struggles
regarding this practice.35,36 Our findings add
to the literature that some nurses find per-
forming sedation ‘‘burdensome’’ and feel
responsible, especially when GPs leave its initi-
ation and monitoring to them and lack suffi-
cient knowledge regarding its use. Nurses
said that they sometimes struggle with the
dilemma of actually administering the medica-
tion and the emotional burden of wondering
whether the medication has hastened the
patient’s death. As nurses may find it
challenging to question the GP’s decisions
openly or to discuss their feelings, it may be
possible that GPs are not always aware of the
responsibility and burden perceived by nurses
when complying with the GP orders.31,37Implications for Policy, Practice, and Research
We believe that open communication
between GPs and nurses regarding their roles
and responsibilities during the use of sedation,
combined with increased multidisciplinary
teamwork, may further improve this practice
at home. Further in-depth research is needed
on the unique roles and responsibilities of
nurses regarding the decision to use sedation
(in the U.K., by using the anticipatory prescrip-
tions) and the performance and monitoring of
sedation. When formulating suggestions for
policy regarding the use of sedation, we sug-
gest keeping in mind that cultural, legal, andorganizational differences may exist between
countries and may affect end-of-life care.
Conclusion
Our study reveals how respondents perceived
that the final decision on the use of sedation in
Belgium and The Netherlands was often made
by the GP, whereas in the U.K., it was often
the nurse who made the decision to use an
anticipatory prescription. These differences
may be the result of different organizational
contexts in the three countries. Furthermore,
nurses in all three countries reported that
they had often initiated and monitored seda-
tion until death in absence of the GP and that
they often experienced this as burdensome.Disclosures and Acknowledgments
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